Cas no 138182-21-5 (6-Chloro-3-indolyl-β-D-galactopyranoside)
6-Chloro-3-indolyl-β-D-galactopyranoside Chemical and Physical Properties
Names and Identifiers
-
- 6-Chloro-3-indolyl--D-galactopyranoside
- Red-Gal(r) 6-Chloro-3-indolyl-!-D-galactoside
- ChloroindolylDgalactopyranoside
- Salmon Galactoside
- 6-Chloro-3-indolyl beta-D-Galactopyranoside [for Biochemical Research]
- 6-Chloro-3-indolyl-beta-D-galactopyranoside
- 6-Chloro-1H-indol-3-yl-beta-D-galactopyranoside
- 6-Chloro-3-indolyl-β-D-galactopyranoside
- -<small>D<
- 6-chloro-1H-indol-3-yl-b-D-galactopyranoside
- 6-Chloro-3-indolyl β-D-Galactopyranoside
- 6-Chloro-3-indolyl-ß
- -D-galactopyranoside
- RED-GAL(R)
- ROSE(TM)-GAL
- ROSE(TM)-GLUCOSIDE
- ROSE-GAL
- SALMON GLU
- SALMON GLUCOSIDE
- SALMON-GAL
- Salmon-GalRose-Gal
- C-5000
- AKOS016003749
- DTXSID10930006
- 6-Chloro-3-indolyl- beta -D-galactopyranoside
- (2S,3R,4S,5R,6R)-2-[(6-chloro-1H-indol-3-yl)oxy]-6-(hydroxymethyl)oxane-3,4,5-triol
- AS-66584
- CS-0185939
- 6-Chloro-1H-indol-3-yl hexopyranosido
- HY-W127769
- Rose-
- 138182-21-5
- 6-Chloro-3-indoxyl-beta-D-galactopyranoside, plant origin
- beta-D-Galactopyranoside, 6-chloro-1H-indol-3-yl
- 6-Chloro-3-indoxyl-beta-D-galactopyranoside
- A854437
- Salmon Gal
- SCHEMBL965625
- C-5010
- MFCD01310928
- A-D-Gal
- (2S,3R,4S,5R,6R)-2-((6-Chloro-1H-indol-3-yl)oxy)-6-(hydroxymethyl)tetrahydro-2H-pyran-3,4,5-triol
- DA-49921
- OQWBAXBVBGNSPW-MBJXGIAVSA-N
- 6-Chloro-1H-indol-3-yl beta-D-galactopyranoside
-
- MDL: MFCD01310928
- Inchi: 1S/C14H16ClNO6/c15-6-1-2-7-8(3-6)16-4-9(7)21-14-13(20)12(19)11(18)10(5-17)22-14/h1-4,10-14,16-20H,5H2/t10-,11+,12+,13-,14-/m1/s1
- InChI Key: OQWBAXBVBGNSPW-MBJXGIAVSA-N
- SMILES: ClC1C=CC2=C(C=1)NC=C2O[C@H]1[C@@H]([C@H]([C@H]([C@@H](CO)O1)O)O)O
Computed Properties
- Exact Mass: 329.06700
- Monoisotopic Mass: 329.067
- Isotope Atom Count: 0
- Hydrogen Bond Donor Count: 5
- Hydrogen Bond Acceptor Count: 7
- Heavy Atom Count: 22
- Rotatable Bond Count: 3
- Complexity: 388
- Covalently-Bonded Unit Count: 1
- Defined Atom Stereocenter Count: 5
- Undefined Atom Stereocenter Count : 0
- Defined Bond Stereocenter Count: 0
- Undefined Bond Stereocenter Count: 0
- Surface Charge: 0
- XLogP3: 0.5
- Topological Polar Surface Area: 115
Experimental Properties
- Color/Form: Bright brown powder
- Density: 1.641±0.06 g/cm3 (20 oC 760 Torr),
- Melting Point: 188-190℃
- Boiling Point: 630.2°Cat760mmHg
- Flash Point: 334.9°C
- Refractive Index: 1.717
- Solubility: Slightly soluble (1.6 g/l) (25 o C),
- Water Partition Coefficient: Insoluble in water. Soluble in DMSO and DMFO, methanol.
- PSA: 115.17000
- LogP: 0.00000
- Solubility: Slightly soluble in water
- Sensitiveness: Moisture Sensitive
6-Chloro-3-indolyl-β-D-galactopyranoside Security Information
- WGK Germany:3
- Hazard Category Code: 36/37/38
- Safety Instruction: S24/25-S36-S26
- FLUKA BRAND F CODES:8-10-21
- Regulatory Condition Code:Class Q (sugars, alkaloids, antibiotics, hormones)
-
Hazardous Material Identification:
- Storage Condition:<0°C
- Risk Phrases:R36/37/38
6-Chloro-3-indolyl-β-D-galactopyranoside Pricemore >>
| Related Categories | No. | Product Name | Cas No. | Purity | Specification | Price | update time | Inquiry |
|---|---|---|---|---|---|---|---|---|
| SHANG HAI XIAN DING Biotechnology Co., Ltd. | C2371-100mg |
6-Chloro-3-indolyl-beta-D-galactopyranoside |
138182-21-5 | 98.0%(LC) | 100mg |
¥990.0 | 2022-05-30 | |
| SHANG HAI XIAN DING Biotechnology Co., Ltd. | C2371-20mg |
6-Chloro-3-indolyl-beta-D-galactopyranoside |
138182-21-5 | 98.0%(LC) | 20mg |
¥290.0 | 2022-05-30 | |
| SHANG HAI XIAN DING Biotechnology Co., Ltd. | F-RU322-25mg |
6-Chloro-3-indolyl-β-D-galactopyranoside |
138182-21-5 | 98% | 25mg |
561.0CNY | 2021-08-06 | |
| Matrix Scientific | 094751-250mg |
6-Chloro-1H-indol-3-yl-beta-D-galactopyranoside, 98% |
138182-21-5 | 98% | 250mg |
$341.00 | 2023-09-09 | |
| Matrix Scientific | 094751-1g |
6-Chloro-1H-indol-3-yl-beta-D-galactopyranoside, 98% |
138182-21-5 | 98% | 1g |
$756.00 | 2023-09-09 | |
| abcr | AB121715-1 g |
6-Chloro-3-indolyl-beta-D-galactopyranoside, 98%; . |
138182-21-5 | 98% | 1 g |
€189.90 | 2023-07-20 | |
| abcr | AB121715-5 g |
6-Chloro-3-indolyl-beta-D-galactopyranoside, 98%; . |
138182-21-5 | 98% | 5 g |
€578.50 | 2023-07-20 | |
| SHANG HAI JI ZHI SHENG HUA Technology Co., Ltd. | X73045-500mg |
(2S,3R,4S,5R,6R)-2-((6-Chloro-1H-indol-3-yl)oxy)-6-(hydroxymethyl)tetrahydro-2H-pyran-3,4,5-triol |
138182-21-5 | ≥98% | 500mg |
¥2358.0 | 2023-09-05 | |
| SHANG HAI JI ZHI SHENG HUA Technology Co., Ltd. | X73045-100mg |
(2S,3R,4S,5R,6R)-2-((6-Chloro-1H-indol-3-yl)oxy)-6-(hydroxymethyl)tetrahydro-2H-pyran-3,4,5-triol |
138182-21-5 | ≥98% | 100mg |
¥1018.0 | 2023-09-05 | |
| SHANG HAI JI ZHI SHENG HUA Technology Co., Ltd. | X73045-20mg |
(2S,3R,4S,5R,6R)-2-((6-Chloro-1H-indol-3-yl)oxy)-6-(hydroxymethyl)tetrahydro-2H-pyran-3,4,5-triol |
138182-21-5 | ≥98% | 20mg |
¥378.0 | 2023-09-05 |
6-Chloro-3-indolyl-β-D-galactopyranoside Suppliers
6-Chloro-3-indolyl-β-D-galactopyranoside Related Literature
-
Gang Pan,Yi-jie Bao,Jie Xu,Tao Liu,Cheng Liu,Yan-yan Qiu,Xiao-jing Shi,Hui Yu,Ting-ting Jia,Xia Yuan,Ze-ting Yuan,Yi-jun Cao RSC Adv., 2016,6, 42109-42119
-
Eunju Nam,Jiyeon Han,Sunhee Choi,Mi Hee Lim Chem. Commun., 2021,57, 7637-7640
-
Goonay Yousefalizadeh,Shideh Ahmadi,Nicholas J. Mosey,Kevin G. Stamplecoskie Nanoscale, 2021,13, 242-252
-
Ivor Lon?ari? Phys. Chem. Chem. Phys., 2015,17, 9436-9445
-
Guang Xu,Wei Zhang,Ying Zhang,Xiaoxia Zhao,Ping Wen,Di Ma RSC Adv., 2018,8, 19353-19361
Additional information on 6-Chloro-3-indolyl-β-D-galactopyranoside
Introduction to 6-Chloro-3-indolyl-β-D-galactopyranoside (CAS No. 138182-21-5)
6-Chloro-3-indolyl-β-D-galactopyranoside, a compound with the chemical identifier CAS No. 138182-21-5, is a specialized glycoside derivative that has garnered significant attention in the field of biochemical research and pharmaceutical development. This compound, characterized by its unique structural motif of an indole ring substituted with a chloro group and linked to a β-D-galactopyranoside moiety, exhibits a range of biological activities that make it a valuable tool in both academic studies and industrial applications.
The structural composition of 6-Chloro-3-indolyl-β-D-galactopyranoside is highly intriguing from a chemical perspective. The indole ring, a well-known pharmacophore in medicinal chemistry, contributes to the compound's potential biological interactions. Specifically, the presence of the chloro substituent at the 6-position and the β-D-galactopyranoside moiety at the 3-position introduces specific electronic and steric properties that influence its reactivity and binding affinity. This precise arrangement makes it an interesting candidate for further investigation in drug design and synthesis.
In recent years, there has been growing interest in glycosides as therapeutic agents due to their diverse biological functions. The β-D-galactopyranoside moiety, in particular, is known for its role in cell recognition processes and its ability to modulate enzyme activity. The introduction of a chloro group on the indole ring enhances the compound's potential as a bioactive molecule by increasing its lipophilicity and altering its electronic distribution. These modifications can significantly affect how the molecule interacts with biological targets, making it a promising candidate for further exploration.
One of the most compelling aspects of 6-Chloro-3-indolyl-β-D-galactopyranoside is its potential application in the development of novel pharmaceuticals. The indole scaffold is widely recognized for its presence in various bioactive natural products and pharmaceuticals, including well-known drugs such as tamoxifen and buspirone. By incorporating this motif into a glycoside structure, researchers can leverage existing knowledge about indole derivatives while exploring new therapeutic possibilities.
Recent studies have begun to uncover the biological activities of 6-Chloro-3-indolyl-β-D-galactopyranoside. Preliminary research suggests that this compound may exhibit inhibitory effects on certain enzymes and receptors, making it a potential candidate for treating various diseases. For instance, its structure resembles that of known enzyme inhibitors, which could make it effective in modulating metabolic pathways or signal transduction processes. Additionally, the galactose moiety could interact with specific carbohydrate-binding proteins, offering opportunities for targeted therapies.
The synthesis of 6-Chloro-3-indolyl-β-D-galactopyranoside is another area of active investigation. The preparation of this compound involves multi-step organic synthesis, requiring careful optimization to ensure high yield and purity. Researchers have been exploring different synthetic routes to improve efficiency and scalability. Advances in synthetic methodologies have enabled the production of this compound in sufficient quantities for both laboratory studies and potential clinical trials.
In conclusion, 6-Chloro-3-indolyl-β-D-galactopyranoside (CAS No. 138182-21-5) is a fascinating compound with significant potential in biochemical research and pharmaceutical development. Its unique structural features make it an attractive candidate for further exploration, particularly in the context of drug design and therapeutic applications. As research continues to uncover new biological activities and synthetic strategies, this compound is poised to play an important role in future medical advancements.
138182-21-5 (6-Chloro-3-indolyl-β-D-galactopyranoside) Related Products
- 35804-66-1(3-Indoxyl-beta-D-glucuronic acid cyclohexylammonium salt)
- 126787-65-3(Indoxyl β-D-Galactopyranoside)
- 17691-02-0(p-Aminophenyl b-D-Lactopyranoside)
- 84380-01-8(a-Arbutin)
- 51997-51-4(4-(2,3-Epoxypropoxy)carbazole)
- 487-60-5(Indican)
- 34213-86-0(4-Aminophenyl a-D-Mannopyranoside)
- 2818-58-8(Phenyl-β-D-galactopyranoside)
- 6044-30-0(2-Naphthyl b-D-Glucopyranoside)
- 497-76-7(Arbutin)